|
|
Wednesday, March 31, 2004
Eidogen Licenses Software to Boehringer Ingelheim
Pasadena-based Eidogen announced that Boehringer Ingelheim is pilot licensing the company's computational drug discovery platform. Eidogen's software is targeted at structural informatics, which looks to combine bioinformatics and cheminformatics. The company's platform is designed to provide target prioritization, lead discovery, and lead optimization for drug discovery companies. Eidogen is backed by Tavistock Life Sciences.
posted on Wednesday, March 31, 2004 (Link to more information)
|
 RSS Feed
 Newsletter
Previous news:
Friday, September 5, 2008
Thursday, September 4, 2008
Wednesday, September 3, 2008
Tuesday, September 2, 2008
Friday, August 29, 2008
|
